203 related articles for article (PubMed ID: 32605549)
1. Protocol of a population-based prospective COVID-19 cohort study Munich, Germany (KoCo19).
Radon K; Saathoff E; Pritsch M; Guggenbühl Noller JM; Kroidl I; Olbrich L; Thiel V; Diefenbach M; Riess F; Forster F; Theis F; Wieser A; Hoelscher M;
BMC Public Health; 2020 Jun; 20(1):1036. PubMed ID: 32605549
[TBL] [Abstract][Full Text] [Related]
2. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
[TBL] [Abstract][Full Text] [Related]
3. From first to second wave: follow-up of the prospective COVID-19 cohort (KoCo19) in Munich (Germany).
Radon K; Bakuli A; Pütz P; Le Gleut R; Guggenbuehl Noller JM; Olbrich L; Saathoff E; Garí M; Schälte Y; Frahnow T; Wölfel R; Pritsch M; Rothe C; Pletschette M; Rubio-Acero R; Beyerl J; Metaxa D; Forster F; Thiel V; Castelletti N; Rieß F; Diefenbach MN; Fröschl G; Bruger J; Winter S; Frese J; Puchinger K; Brand I; Kroidl I; Wieser A; Hoelscher M; Hasenauer J; Fuchs C;
BMC Infect Dis; 2021 Sep; 21(1):925. PubMed ID: 34493217
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
[TBL] [Abstract][Full Text] [Related]
5. PROTECT Trial: A cluster-randomized study with hydroxychloroquine versus observational support for prevention or early-phase treatment of Coronavirus disease (COVID-19): A structured summary of a study protocol for a randomized controlled trial.
Nanni O; Viale P; Vertogen B; Lilli C; Zingaretti C; Donati C; Masini C; Monti M; Serra P; Vespignani R; Grossi V; Biggeri A; Scarpi E; Galardi F; Bertoni L; Colamartini A; Falcini F; Altini M; Massa I; Gaggeri R; Martinelli G
Trials; 2020 Jul; 21(1):689. PubMed ID: 32736597
[TBL] [Abstract][Full Text] [Related]
6. Protocol for a national probability survey using home specimen collection methods to assess prevalence and incidence of SARS-CoV-2 infection and antibody response.
Siegler AJ; Sullivan PS; Sanchez T; Lopman B; Fahimi M; Sailey C; Frankel M; Rothenberg R; Kelley CF; Bradley H
Ann Epidemiol; 2020 Sep; 49():50-60. PubMed ID: 32791199
[TBL] [Abstract][Full Text] [Related]
7. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the remote early detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE;
Trials; 2021 Jun; 22(1):412. PubMed ID: 34158099
[TBL] [Abstract][Full Text] [Related]
8. A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative Group.
Al-Shamsi HO; Alhazzani W; Alhuraiji A; Coomes EA; Chemaly RF; Almuhanna M; Wolff RA; Ibrahim NK; Chua MLK; Hotte SJ; Meyers BM; Elfiki T; Curigliano G; Eng C; Grothey A; Xie C
Oncologist; 2020 Jun; 25(6):e936-e945. PubMed ID: 32243668
[TBL] [Abstract][Full Text] [Related]
9. ChemoPROphyLaxIs with hydroxychloroquine For covId-19 infeCtious disease (PROLIFIC) to prevent covid-19 infection in frontline healthcare workers: A structured summary of a study protocol for a randomised controlled trial.
McEniery CM; Fisk M; Miles K; Kaloyirou F; Hubsch A; Smith J; Wilkinson IB; Cheriyan J
Trials; 2020 Jul; 21(1):604. PubMed ID: 32616067
[TBL] [Abstract][Full Text] [Related]
10. The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.
Chaccour C; Ruiz-Castillo P; Richardson MA; Moncunill G; Casellas A; Carmona-Torre F; Giráldez M; Mota JS; Yuste JR; Azanza JR; Fernández M; Reina G; Dobaño C; Brew J; Sadaba B; Hammann F; Rabinovich R
Trials; 2020 Jun; 21(1):498. PubMed ID: 32513289
[TBL] [Abstract][Full Text] [Related]
11. Using BCG vaccine to enhance non-specific protection of health care workers during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trial in Denmark.
Madsen AMR; Schaltz-Buchholzer F; Benfield T; Bjerregaard-Andersen M; Dalgaard LS; Dam C; Ditlev SB; Faizi G; Johansen IS; Kofoed PE; Kristensen GS; Loekkegaard ECL; Mogensen CB; Mohamed L; Ostenfeld A; Oedegaard ES; Soerensen MK; Wejse C; Jensen AKG; Nielsen S; Krause TG; Netea MG; Aaby P; Benn CS
Trials; 2020 Sep; 21(1):799. PubMed ID: 32943115
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.
Barnabas RV; Brown E; Bershteyn A; Miller RS; Wener M; Celum C; Wald A; Chu H; Wesche D; Baeten JM;
Trials; 2020 Jun; 21(1):475. PubMed ID: 32493478
[TBL] [Abstract][Full Text] [Related]
13. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
14. Household secondary attack rate of COVID-19 and associated determinants in Guangzhou, China: a retrospective cohort study.
Jing QL; Liu MJ; Zhang ZB; Fang LQ; Yuan J; Zhang AR; Dean NE; Luo L; Ma MM; Longini I; Kenah E; Lu Y; Ma Y; Jalali N; Yang ZC; Yang Y
Lancet Infect Dis; 2020 Oct; 20(10):1141-1150. PubMed ID: 32562601
[TBL] [Abstract][Full Text] [Related]
15. The representative COVID-19 cohort Munich (KoCo19): from the beginning of the pandemic to the Delta virus variant.
Le Gleut R; Plank M; Pütz P; Radon K; Bakuli A; Rubio-Acero R; Paunovic I; Rieß F; Winter S; Reinkemeyer C; Schälte Y; Olbrich L; Hannes M; Kroidl I; Noreña I; Janke C; Wieser A; Hoelscher M; Fuchs C; Castelletti N;
BMC Infect Dis; 2023 Jul; 23(1):466. PubMed ID: 37442952
[TBL] [Abstract][Full Text] [Related]
16. Quarantine alone or in combination with other public health measures to control COVID-19: a rapid review.
Nussbaumer-Streit B; Mayr V; Dobrescu AI; Chapman A; Persad E; Klerings I; Wagner G; Siebert U; Christof C; Zachariah C; Gartlehner G
Cochrane Database Syst Rev; 2020 Apr; 4(4):CD013574. PubMed ID: 32267544
[TBL] [Abstract][Full Text] [Related]
17. Impact of self-imposed prevention measures and short-term government-imposed social distancing on mitigating and delaying a COVID-19 epidemic: A modelling study.
Teslya A; Pham TM; Godijk NG; Kretzschmar ME; Bootsma MCJ; Rozhnova G
PLoS Med; 2020 Jul; 17(7):e1003166. PubMed ID: 32692736
[TBL] [Abstract][Full Text] [Related]
18. Dynamic Panel Estimate-Based Health Surveillance of SARS-CoV-2 Infection Rates to Inform Public Health Policy: Model Development and Validation.
Oehmke JF; Oehmke TB; Singh LN; Post LA
J Med Internet Res; 2020 Sep; 22(9):e20924. PubMed ID: 32915762
[TBL] [Abstract][Full Text] [Related]
19. Predicting COVID-19 spread in the face of control measures in West Africa.
Taboe HB; Salako KV; Tison JM; Ngonghala CN; Glèlè Kakaï R
Math Biosci; 2020 Oct; 328():108431. PubMed ID: 32738248
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 Seroprevalence among a Southern U.S. Population Indicates Limited Asymptomatic Spread under Physical Distancing Measures.
Barzin A; Schmitz JL; Rosin S; Sirpal R; Almond M; Robinette C; Wells S; Hudgens M; Olshan A; Deen S; Krejci P; Quackenbush E; Chronowski K; Cornaby C; Goins J; Butler L; Aucoin J; Boyer K; Faulk J; Alston-Johnson D; Page C; Zhou Y; Fiscus L; Damania B; Dittmer DP; Peden DB
mBio; 2020 Sep; 11(5):. PubMed ID: 32994333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
